Fulcrum Therapeutics Inc
(FULC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,677 | -32,588 | -22,964 | N/A | N/A |
| Depreciation Amortization | 2,053 | 1,345 | 715 | N/A | N/A |
| Accounts payable and accrued liabilities | 803 | -20 | 208 | N/A | N/A |
| Other Working Capital | 11,326 | 6,522 | 804 | N/A | N/A |
| Other Operating Activity | 29,012 | 2,179 | 1,163 | 0 | 0 |
| Operating Cash Flow | $-39,483 | $-22,562 | $-20,074 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -853 | -8,981 | -1,908 | N/A | N/A |
| Other Investing Activity | -91 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-944 | $-8,981 | $-1,908 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -45 | -70 | N/A | N/A | N/A |
| Common Stock Issued | 64,422 | 12 | 41 | N/A | N/A |
| Other Financing Activity | -34 | 105,083 | 17,621 | 0 | 0 |
| Financing Cash Flow | $64,343 | $105,025 | $17,662 | $N/A | $N/A |
| Beginning Cash Position | 73,889 | 407 | 4,727 | N/A | N/A |
| End Cash Position | 97,805 | 73,889 | 407 | N/A | N/A |
| Net Cash Flow | $23,916 | $73,482 | $-4,320 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,483 | -22,562 | -20,074 | N/A | N/A |
| Capital Expenditure | -853 | -8,981 | -1,908 | N/A | N/A |
| Free Cash Flow | -40,336 | -31,543 | -21,982 | 0 | 0 |